These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 33000758)

  • 21. Neck myoclonia with absence seizures in an Indian girl.
    Jain P; Sharma S; Aneja S
    J Child Neurol; 2014 Nov; 29(11):NP131-4. PubMed ID: 24556548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in epilepsy with eyelid myoclonia (Jeavons syndrome).
    Nilo A; Crespel A; Genton P; Macorig G; Gigli GL; Gélisse P
    Rev Neurol (Paris); 2023 Dec; 179(10):1081-1085. PubMed ID: 37598086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overlap cases of eyelid myoclonia with absences and juvenile myoclonic epilepsy.
    Destina Yalçin A; Forta H; Kiliç E
    Seizure; 2006 Sep; 15(6):359-65. PubMed ID: 16793291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eyelid myoclonia with absences (EMA) in two monovular twins.
    DeMarco P
    Clin Electroencephalogr; 1989 Jul; 20(3):193-5. PubMed ID: 2502335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epilepsy with eyelid myoclonias (Jeavons syndrome): An electro-clinical study of 40 patients from childhood to adulthood.
    Nilo A; Crespel A; Genton P; Macorig G; Gigli GL; Gelisse P
    Seizure; 2021 Apr; 87():30-38. PubMed ID: 33677402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence status induced by lacosamide adjunctive therapy.
    Ákos Szabó C; Morgan LC; Sonnenberg S; Karkar KM
    Epileptic Disord; 2019 Feb; 21(1):97-101. PubMed ID: 30782579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epilepsy with Eyelid myoclonias - A diagnosis concealed in other genetic generalized epilepsies with photoparoxysmal response.
    Zawar I; Toribio MGG; Xu X; Alnakhli RS; Benech D; Valappil AMN; Wyllie E; Burgess R; Kotagal P; Lachhwani D; Gupta A; Knight EP
    Epilepsy Res; 2022 Mar; 181():106886. PubMed ID: 35180638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unmasking of myoclonus by lacosamide in generalized epilepsy.
    Birnbaum D; Koubeissi M
    Epilepsy Behav Case Rep; 2017; 7():28-30. PubMed ID: 28239547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of epilepsy with lacosamide in a patient with ring chromosome 20 syndrome.
    Tayama T; Mori T; Goji A; Toda Y; Kagami S
    Brain Dev; 2020 Jun; 42(6):473-476. PubMed ID: 32247529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case series of lacosamide as adjunctive therapy in refractory sleep-related hypermotor epilepsy (previously nocturnal frontal lobe epilepsy).
    Samarasekera SR; Berkovic SF; Scheffer IE
    J Sleep Res; 2018 Oct; 27(5):e12669. PubMed ID: 29479765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Video-EEG study in an adult and a child with eyelid myoclonia with absences.
    Burneo JG; Miller S; Bebin EM; Prasad A
    Epileptic Disord; 2004 Dec; 6(4):287-91. PubMed ID: 15634626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous lacosamide for treatment of absence status epilepticus in genetic generalized epilepsy: A case report and review of literature.
    Reif PS; Männer A; Willems LM; Kay L; Zöllner JP; Klein KM; Rosenow F; Strzelczyk A
    Acta Neurol Scand; 2018 Sep; 138(3):259-262. PubMed ID: 29633241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes.
    Okanishi T; Fujii Y; Sakuma S; Shiraishi H; Motoi H; Yazaki K; Enoki H; Fujimoto A
    Brain Dev; 2022 Jun; 44(6):380-385. PubMed ID: 35241306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eyelid myoclonia with absences: Electroclinical features and prognostic factors.
    Giuliano L; Fatuzzo D; Mainieri G; Maira G; Elia M; Ferlazzo E; Gasparini S; Nicoletti A; Sofia V; Zappia M
    Epilepsia; 2019 Jun; 60(6):1104-1113. PubMed ID: 31087661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lacosamide treatment of juvenile myoclonic epilepsy.
    Afra P; Adamolekun B
    Seizure; 2012 Apr; 21(3):202-4. PubMed ID: 22281192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):82-90. PubMed ID: 29898974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA; Holmes GL
    J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benign myoclonic epilepsy of infancy evolving to Jeavons syndrome.
    Moutaouakil F; El Otmani H; Fadel H; El Moutawakkil B; Slassi I
    Pediatr Neurol; 2010 Sep; 43(3):213-6. PubMed ID: 20691946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.